Skip to main content

Table 1 Patient characteristics

From: Use of MIRUS™ for MAC-driven application of isoflurane, sevoflurane, and desflurane in postoperative ICU patients: a randomized controlled trial

  Isoflurane [n = 10] Sevoflurane [n = 10] Desflurane [n = 10] All [n = 30] Statistics
Demography
 Sex (♂/♀) [n] 8/2 7/3 5/5 20/10 p = 0.500
 Age [years] 65.2 ± 9.8 68.4 ± .9.6 59.9 ± 13.29 64.5 ± 11.2 p = 0.238
 Height [cm] 176.5 ± 8.5 176.6 ± 7.3 167.8 ± 110.7 173.6 ± 9.6 p = 0.057
 Weight [kg] 84.7 ± 10.2 83.2 ± 20.8 68.7 ± 15.7 78.9 ± 17.2 p = 0.067
 ASA [score] 2 [1.75−2] 2 [2] 2 [2] 2 [2] p = 0.484
 SAPS [score] 28.5 ± 10.4 33.9 ± 10.4 26.2 ± 9.47 29.53 ± 10.3 p = 0.234
Comorbidities [n]
 Hypertension 4 7 7 18 p = 0.452
 Coronary heart disease 2 3 0 5 p = 0.321
 PAOD 0 1 1 2 p > 0.999
 Nicotine 4 4 2 10 p = 0.698
 COPD 1 0 1 2 p > 0.999
 Renal insufficiency 1 1 0 2 p > 0.999
 Diabetes 3 3 3 9 p > 0.999
 Alcohol abuse 0 1 4 5 p = 0.094
 Previous opioid medication 0 0 3 3 p = 0.089
Surgeries [n]
 Aortic surgery 1 1 3 5 p = 0.574
 Pancreatic surgery 2 0 3 5 p = 0.321
 Esophagectomy 5 4 2 11 p = 0.321
 HIPEC 1 2 1 4 p > 0.999
 Necrotizing fasciitis 0 1 0 1 p > 0.999
 Spinal fusion 1 2 1 4 p > 0.999
Epidural analgesia [n] 3 2 3 8 p > 0.999
  1. Demographics, comorbidities, the kind of surgeries, and the number of patients requiring epidural analgesia were comparable throughout all groups. Values are given as mean ± SD, median [1st–3rd quartiles], or number
  2. PAOD peripheral arterial occlusive disease, COPD chronic obstructive pulmonary disease, HIPEC hyperthermic intraperitoneal chemotherapy